Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 452

1.

Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian Cancer.

Asaka S, Davis C, Lin SF, Wang TL, Heaphy CM, Shih IM.

Am J Surg Pathol. 2019 May 17. doi: 10.1097/PAS.0000000000001283. [Epub ahead of print]

PMID:
31107721
2.

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target.

Chen LY, Huang RL, Chan MW, Yan PS, Huang TS, Wu RC, Suryo Rahmanto Y, Su PH, Weng YC, Chou JL, Chao TK, Wang YC, Shih IM, Lai HC.

J Pathol. 2019 Mar 18. doi: 10.1002/path.5266. [Epub ahead of print]

PMID:
30883733
3.

Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma.

Chui MH, Vang R, Wang TL, Shih IM, VandenBussche CJ.

Cancer Cytopathol. 2019 Mar;127(3):192-201. doi: 10.1002/cncy.22110. Epub 2019 Mar 12.

PMID:
30861338
4.

Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.

Bast RC Jr, Matulonis UA, Sood AK, Ahmed AA, Amobi AE, Balkwill FR, Wielgos-Bonvallet M, Bowtell DDL, Brenton JD, Brugge JS, Coleman RL, Draetta GF, Doberstein K, Drapkin RI, Eckert MA, Edwards RP, Elias KM, Ennis D, Futreal A, Gershenson DM, Greenberg RA, Huntsman DG, Ji JXY, Kohn EC, Iavarone C, Lengyel ER, Levine DA, Lord CJ, Lu Z, Mills GB, Modugno F, Nelson BH, Odunsi K, Pilsworth JA, Rottapel RK, Powell DJ Jr, Shen L, Shih IM, Spriggs DR, Walton J, Zhang K, Zhang R, Zou L.

Cancer. 2019 Mar 5. doi: 10.1002/cncr.32004. [Epub ahead of print]

PMID:
30835824
5.

Follicular fluid has more to offer: Insulin-like growth factor axis on ovarian carcinogenesis.

Chu T, Shih IM.

EBioMedicine. 2019 Mar;41:30-31. doi: 10.1016/j.ebiom.2019.02.030. Epub 2019 Feb 21. No abstract available.

6.

Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment.

Hu Z, Zhou J, Jiang J, Yuan J, Zhang Y, Wei X, Loo N, Wang Y, Pan Y, Zhang T, Zhong X, Long M, Montone KT, Tanyi JL, Fan Y, Wang TL, Shih IM, Hu X, Zhang L.

Nat Commun. 2019 Feb 13;10(1):733. doi: 10.1038/s41467-019-08554-x.

7.

Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer.

Yen TT, Wang TL, Fader AN, Shih IM, Gaillard S.

Int J Gynecol Pathol. 2019 Feb 7. doi: 10.1097/PGP.0000000000000585. [Epub ahead of print]

PMID:
30741844
8.

PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function.

Whelan S, Ophir E, Kotturi MF, Levy O, Ganguly S, Leung L, Vaknin I, Kumar S, Dassa L, Hansen K, Bernados D, Murter B, Soni A, Taube JM, Fader AN, Wang TL, Shih IM, White M, Pardoll DM, Liang SC.

Cancer Immunol Res. 2019 Feb;7(2):257-268. doi: 10.1158/2326-6066.CIR-18-0442. Epub 2019 Jan 18.

PMID:
30659054
9.

The association between lifestyle factors and Parkinson's disease progression and mortality.

Paul KC, Chuang YH, Shih IF, Keener A, Bordelon Y, Bronstein JM, Ritz B.

Mov Disord. 2019 Jan;34(1):58-66. doi: 10.1002/mds.27577.

PMID:
30653734
10.

Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.

Wu RC, Wang P, Lin SF, Zhang M, Song Q, Chu T, Wang BG, Kurman RJ, Vang R, Kinzler K, Tomasetti C, Jiao Y, Shih IM, Wang TL.

J Pathol. 2019 May;248(1):41-50. doi: 10.1002/path.5219. Epub 2019 Feb 15.

PMID:
30560554
11.

Long Interspersed Nuclear Element 1 Retrotransposons Become Deregulated during the Development of Ovarian Cancer Precursor Lesions.

Pisanic TR 2nd, Asaka S, Lin SF, Yen TT, Sun H, Bahadirli-Talbott A, Wang TH, Burns KH, Wang TL, Shih IM.

Am J Pathol. 2019 Mar;189(3):513-520. doi: 10.1016/j.ajpath.2018.11.005. Epub 2018 Dec 13.

PMID:
30553834
12.

Proteome-wide Tyrosine Phosphorylation Analysis Reveals Dysregulated Signaling Pathways in Ovarian Tumors.

Song G, Chen L, Zhang B, Song Q, Yu Y, Moore C, Wang TL, Shih IM, Zhang H, Chan DW, Zhang Z, Zhu H.

Mol Cell Proteomics. 2019 Mar;18(3):448-460. doi: 10.1074/mcp.RA118.000851. Epub 2018 Dec 6.

PMID:
30523211
13.

T cell-inflamed phenotype and increased Foxp3 expression in infiltrating T-cells of mismatch-repair deficient endometrial cancers.

Asaka S, Yen TT, Wang TL, Shih IM, Gaillard S.

Mod Pathol. 2019 Apr;32(4):576-584. doi: 10.1038/s41379-018-0172-x. Epub 2018 Nov 6.

PMID:
30401949
14.

Gallium nitride nanowire as a linker of molybdenum sulfides and silicon for photoelectrocatalytic water splitting.

Zhou B, Kong X, Vanka S, Chu S, Ghamari P, Wang Y, Pant N, Shih I, Guo H, Mi Z.

Nat Commun. 2018 Sep 21;9(1):3856. doi: 10.1038/s41467-018-06140-1.

15.

Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.

Visvanathan K, Shaw P, May BJ, Bahadirli-Talbott A, Kaushiva A, Risch H, Narod S, Wang TL, Parkash V, Vang R, Levine DA, Soslow R, Kurman R, Shih IM.

Cancer Prev Res (Phila). 2018 Nov;11(11):697-706. doi: 10.1158/1940-6207.CAPR-18-0009. Epub 2018 Sep 19.

PMID:
30232083
16.

Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic.

Stone ML, Chiappinelli KB, Li H, Murphy LM, Travers ME, Topper MJ, Mathios D, Lim M, Shih IM, Wang TL, Hung CF, Bhargava V, Wiehagen KR, Cowley GS, Bachman KE, Strick R, Strissel PL, Baylin SB, Zahnow CA.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8583-E8584. doi: 10.1073/pnas.1811015115. Epub 2018 Sep 4. No abstract available.

17.

Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.

Yen TT, Miyamoto T, Asaka S, Chui MH, Wang Y, Lin SF, Stone RL, Fader AN, Asaka R, Kashima H, Shiozawa T, Wang TL, Shih IM, Tanner EJ 3rd.

Gynecol Oncol. 2018 Sep;150(3):426-431. doi: 10.1016/j.ygyno.2018.06.025. Epub 2018 Jul 4.

PMID:
30126589
18.

Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions.

Pisanic TR 2nd, Cope LM, Lin SF, Yen TT, Athamanolap P, Asaka R, Nakayama K, Fader AN, Wang TH, Shih IM, Wang TL.

Clin Cancer Res. 2018 Dec 15;24(24):6536-6547. doi: 10.1158/1078-0432.CCR-18-1199. Epub 2018 Aug 14.

PMID:
30108103
19.

Photoelectrochemical CO2 Reduction into Syngas with the Metal/Oxide Interface.

Chu S, Ou P, Ghamari P, Vanka S, Zhou B, Shih I, Song J, Mi Z.

J Am Chem Soc. 2018 Jun 27;140(25):7869-7877. doi: 10.1021/jacs.8b03067. Epub 2018 Jun 15.

PMID:
29905471
20.

Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway.

Yu Y, Suryo Rahmanto Y, Lee MH, Wu PH, Phillip JM, Huang CH, Vitolo MI, Gaillard S, Martin SS, Wirtz D, Shih IM, Wang TL.

Oncogene. 2018 Jul;37(28):3778-3789. doi: 10.1038/s41388-018-0241-0. Epub 2018 Apr 11.

21.

Independent development of endometrial epithelium and stroma within the same endometriosis.

Noë M, Ayhan A, Wang TL, Shih IM.

J Pathol. 2018 Jul;245(3):265-269. doi: 10.1002/path.5082. Epub 2018 May 2.

PMID:
29604057
22.

Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer.

Fukumoto T, Park PH, Wu S, Fatkhutdinov N, Karakashev S, Nacarelli T, Kossenkov AV, Speicher DW, Jean S, Zhang L, Wang TL, Shih IM, Conejo-Garcia JR, Bitler BG, Zhang R.

Cell Rep. 2018 Mar 27;22(13):3393-3400. doi: 10.1016/j.celrep.2018.03.019.

23.

Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.

Wang Y, Li L, Douville C, Cohen JD, Yen TT, Kinde I, Sundfelt K, Kjær SK, Hruban RH, Shih IM, Wang TL, Kurman RJ, Springer S, Ptak J, Popoli M, Schaefer J, Silliman N, Dobbyn L, Tanner EJ, Angarita A, Lycke M, Jochumsen K, Afsari B, Danilova L, Levine DA, Jardon K, Zeng X, Arseneau J, Fu L, Diaz LA Jr, Karchin R, Tomasetti C, Kinzler KW, Vogelstein B, Fader AN, Gilbert L, Papadopoulos N.

Sci Transl Med. 2018 Mar 21;10(433). pii: eaap8793. doi: 10.1126/scitranslmed.aap8793.

24.

International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group.

Cho KR, Cooper K, Croce S, Djordevic B, Herrington S, Howitt B, Hui P, Ip P, Koebel M, Lax S, Quade BJ, Shaw P, Vidal A, Yemelyanova A, Clarke B, Hedrick Ellenson L, Longacre TA, Shih IM, McCluggage WG, Malpica A, Oliva E, Parkash V, Matias-Guiu X.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S114-S122. doi: 10.1097/PGP.0000000000000496.

25.

Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer.

Chen BB, Tien YW, Chang MC, Cheng MF, Chang YT, Yang SH, Wu CH, Kuo TC, Shih IL, Yen RF, Shih TT.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1205-1217. doi: 10.1007/s00259-018-3960-0. Epub 2018 Feb 23.

PMID:
29476229
26.

CINdex: A Bioconductor Package for Analysis of Chromosome Instability in DNA Copy Number Data.

Song L, Bhuvaneshwar K, Wang Y, Feng Y, Shih IM, Madhavan S, Gusev Y.

Cancer Inform. 2017 Dec 13;16:1176935117746637. doi: 10.1177/1176935117746637. eCollection 2017.

27.

Indonesian scientists embrace preprint server.

Shih I.

Nature. 2018 Jan 11;553(7687):139. doi: 10.1038/d41586-017-08838-6. No abstract available.

PMID:
29323327
28.

Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.

Ojalvo LS, Thompson ED, Wang TL, Meeker AK, Shih IM, Fader AN, Cimino-Mathews A, Emens LA.

Hum Pathol. 2018 Apr;74:135-147. doi: 10.1016/j.humpath.2017.12.010. Epub 2017 Dec 27.

PMID:
29288043
29.

Precancerous Lesions of Ovarian Cancer-A US Perspective.

Visvanathan K, Wang TL, Shih IM.

J Natl Cancer Inst. 2018 Jul 1;110(7):692-693. doi: 10.1093/jnci/djx269. No abstract available.

PMID:
29281080
30.

Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.

Stone ML, Chiappinelli KB, Li H, Murphy LM, Travers ME, Topper MJ, Mathios D, Lim M, Shih IM, Wang TL, Hung CF, Bhargava V, Wiehagen KR, Cowley GS, Bachman KE, Strick R, Strissel PL, Baylin SB, Zahnow CA.

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10981-E10990. doi: 10.1073/pnas.1712514114. Epub 2017 Dec 4.

31.

The novel ZIP4 regulation and its role in ovarian cancer.

Fan Q, Cai Q, Li P, Wang W, Wang J, Gerry E, Wang TL, Shih IM, Nephew KP, Xu Y.

Oncotarget. 2017 Sep 30;8(52):90090-90107. doi: 10.18632/oncotarget.21435. eCollection 2017 Oct 27.

32.

Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach.

Wu RC, Veras E, Lin J, Gerry E, Bahadirli-Talbott A, Baras A, Ayhan A, Shih IM, Wang TL.

Cold Spring Harb Mol Case Stud. 2017 Nov 21;3(6). pii: a001693. doi: 10.1101/mcs.a001693. Print 2017 Nov.

33.

Endometriosis: benign, malignant, or something in between?

Chui MH, Wang TL, Shih IM.

Oncotarget. 2017 Sep 19;8(45):78263-78264. doi: 10.18632/oncotarget.21051. eCollection 2017 Oct 3. No abstract available.

34.

High grade serous ovarian carcinomas originate in the fallopian tube.

Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, Bhattacharya R, Novak M, Jones S, Phallen J, Hruban CA, Hirsch MS, Lin DI, Schwartz L, Maire CL, Tille JC, Bowden M, Ayhan A, Wood LD, Scharpf RB, Kurman R, Wang TL, Shih IM, Karchin R, Drapkin R, Velculescu VE.

Nat Commun. 2017 Oct 23;8(1):1093. doi: 10.1038/s41467-017-00962-1.

35.

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma.

Ducie J, Dao F, Considine M, Olvera N, Shaw PA, Kurman RJ, Shih IM, Soslow RA, Cope L, Levine DA.

Nat Commun. 2017 Oct 17;8(1):990. doi: 10.1038/s41467-017-01217-9.

36.

Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma.

Xing D, Suryo Rahmanto Y, Zeppernick F, Hannibal CG, Kjaer SK, Vang R, Shih IM, Wang TL.

Hum Pathol. 2017 Oct;68:87-91. doi: 10.1016/j.humpath.2017.08.021. Epub 2017 Sep 2.

37.

Toward Single Atom Chains with Exfoliated Tellurium.

Churchill HOH, Salamo GJ, Yu SQ, Hironaka T, Hu X, Stacy J, Shih I.

Nanoscale Res Lett. 2017 Aug 10;12(1):488. doi: 10.1186/s11671-017-2255-x.

38.

Lymphocytic hidradenitis: A distinctive histopathological finding of annular erythema of Sjögren syndrome.

Hsu HC, Lin CY, Shih IH, Shen SC.

Australas J Dermatol. 2018 Aug;59(3):e198-e202. doi: 10.1111/ajd.12700. Epub 2017 Aug 3.

PMID:
28771678
39.

Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?

Fader AN, Bergstrom J, Jernigan A, Tanner EJ 3rd, Roche KL, Stone RL, Levinson KL, Ricci S, Wethingon S, Wang TL, Shih IM, Yang B, Zhang G, Armstrong DK, Gaillard S, Michener C, DeBernardo R, Rose PG.

Gynecol Oncol. 2017 Oct;147(1):85-91. doi: 10.1016/j.ygyno.2017.07.127. Epub 2017 Jul 30.

PMID:
28768570
40.

Physical activity modifies the influence of apolipoprotein E ε4 allele and type 2 diabetes on dementia and cognitive impairment among older Mexican Americans.

Shih IF, Paul K, Haan M, Yu Y, Ritz B.

Alzheimers Dement. 2018 Jan;14(1):1-9. doi: 10.1016/j.jalz.2017.05.005. Epub 2017 Jul 8.

41.

Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM.

Intest Res. 2017 Jul;15(3):285-310. doi: 10.5217/ir.2017.15.3.285. Epub 2017 Jun 12. Review.

42.

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM.

Intest Res. 2017 Jul;15(3):266-284. doi: 10.5217/ir.2017.15.3.266. Epub 2017 Jun 12. Review.

43.

PET/MRI for evaluating subclinical inflammation of ulcerative colitis.

Shih IL, Wei SC, Yen RF, Chang CC, Ko CL, Lin BR, Shun CT, Liu KL, Wong JM, Chang YC.

J Magn Reson Imaging. 2018 Mar;47(3):737-745. doi: 10.1002/jmri.25795. Epub 2017 Jun 22.

PMID:
28640521
44.

Cancer-Associated Mutations in Endometriosis without Cancer.

Anglesio MS, Papadopoulos N, Ayhan A, Nazeran TM, Noë M, Horlings HM, Lum A, Jones S, Senz J, Seckin T, Ho J, Wu RC, Lac V, Ogawa H, Tessier-Cloutier B, Alhassan R, Wang A, Wang Y, Cohen JD, Wong F, Hasanovic A, Orr N, Zhang M, Popoli M, McMahon W, Wood LD, Mattox A, Allaire C, Segars J, Williams C, Tomasetti C, Boyd N, Kinzler KW, Gilks CB, Diaz L, Wang TL, Vogelstein B, Yong PJ, Huntsman DG, Shih IM.

N Engl J Med. 2017 May 11;376(19):1835-1848. doi: 10.1056/NEJMoa1614814.

45.

Occupational and recreational physical activity and Parkinson's disease in Denmark.

Shih IF, Starhof C, Lassen CF, Hansen J, Liew Z, Ritz B.

Scand J Work Environ Health. 2017 May 1;43(3):210-216. doi: 10.5271/sjweh.3633. Epub 2017 Mar 20.

46.

Human transposon insertion profiling: Analysis, visualization and identification of somatic LINE-1 insertions in ovarian cancer.

Tang Z, Steranka JP, Ma S, Grivainis M, Rodić N, Huang CR, Shih IM, Wang TL, Boeke JD, Fenyö D, Burns KH.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):E733-E740. doi: 10.1073/pnas.1619797114. Epub 2017 Jan 17.

47.

Tubal origin of ovarian cancer - the double-edged sword of haemoglobin.

Lin SF, Gerry E, Shih IM.

J Pathol. 2017 May;242(1):3-6. doi: 10.1002/path.4875. Epub 2017 Mar 23. Review.

PMID:
28054715
48.

Cancer Implications for Patients with Endometriosis.

Wilbur MA, Shih IM, Segars JH, Fader AN.

Semin Reprod Med. 2017 Jan;35(1):110-116. doi: 10.1055/s-0036-1597120. Epub 2017 Jan 3. Review.

PMID:
28049216
49.
50.

Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1.

Jung JG, Shih IM, Park JT, Gerry E, Kim TH, Ayhan A, Handschuh K, Davidson B, Fader AN, Selleri L, Wang TL.

Cancer Res. 2016 Nov 1;76(21):6351-6361. Epub 2016 Sep 2.

Supplemental Content

Support Center